🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
TMO
NYSE
🇺🇸 US
Thermo Fisher Scientific
Healthcare
20Score
DipBuster Score™
$681.08
+$7.26 (+1.08%)
Live price · Source: Yahoo
52-Week Position
$435.27
91% of range
$705.79
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
BetaN/A
52W High$705.79
52W Low$435.27
DipBuster Brief
Key signals at a glance
Zone: Sell / Avoid
Bearish
Near 52-Week High — Asymmetric Risk
At 91% of its annual range the stock is close to its peak. New buyers face limited upside and meaningful downside if sentiment shifts.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position91% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta—
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at Thermo Fisher Scientific (TMO), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-09-26 | Keith R. Alexandra | BUY | 46 |
| 2026-09-26 | Weisler Dion J | BUY | 56 |
| 2026-09-26 | Lynch Karen S | BUY | 46 |
| 2026-09-26 | Sperling Scott M | BUY | 63 |
| 2026-09-26 | Johnson Jennifer M | BUY | 46 |
| 2026-08-31 | Pettiti Gianluca | SELL | 3,733 |
| 2026-08-31 | Pettiti Gianluca | SELL | 3,733 |
| 2026-08-31 | Pettiti Gianluca | BUY | 3,733 |
| 2026-08-31 | Pettiti Gianluca | SELL | 400 |
| 2026-08-28 | Meyer James | SELL | 114 |
Valuation
P/E RatioN/A
Market CapN/A
BetaN/A
Dividend/yrNone
52W High$705.79
52W Low$435.27
52-Week Range
$435.27Now$705.79
91% through annual range
From 52W High−3.5%
From 52W Low+56.5%
📖 Plain English Summary
Thermo Fisher Scientific is at 91% of its 52-week range.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for TMO
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — TMO
Heuristic · balance sheet, insider filings, price data, academic research
Thermo Fisher Scientific — DipBuster Score 20/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track Thermo Fisher Scientific free
Add TMO to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Hargreaves Lansdown
UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
4/25
Momentum & Volume
11/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
0
/100 · NEUTRAL
dip depth
0/25
oversold rsi
0/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 20/100
📊
Run a full check in the AI analysis tab for a deeper look.